FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
FURX was delisted on the 1st of July, 2014.
0 hedge funds and large institutions have $0 invested in FURIEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 102 closing their positions.
100% less funds holding
Funds holding: 102 → 0 (-102)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $728M → $0 (-$728M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 102
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$85.4M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$79.2M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$77.9M |
| 4 |
Morgan Stanley
New York
|
-$71.4M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$40.1M |
FURX Hedge Fund Activity: Q3 2014 in Review
0 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) for Q3 2014, worth a combined $0 — down 100% from $728M a quarter earlier.
Sellers outnumbered buyers: 102 funds closed out of FURX and 0 opened new positions — a net loss of 102 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $85.4M sold.
- 0 institutional investors held FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) as of Q3 2014, down from 102 in Q2 2014.
- Funds reported $0 of FURIEX PHARMACEUTICALS INC COM STK (DE) stock for Q3 2014, down 100% quarter-over-quarter.
- 0 funds opened new FURIEX PHARMACEUTICALS INC COM STK (DE) positions in Q3 2014 and 102 closed out, a net change of -102 holders.
- The largest FURIEX PHARMACEUTICALS INC COM STK (DE) seller in Q3 2014 was D.E. Shaw & Co, an estimated $85.4M sold.
Based on aggregated 13F filings for Q3 2014.